Disease The intractable diseases designated by MHLW, Japan


Diseases : 348 - Clinical trials : 39,610 / Drugs : 18,765 - ( DrugBank : 2,435 ) / Drug target genes : 703 - Drug target pathways : 305

  
Disease group: Hearing and balance disorders  
ID Disease name [Group] Clinical trial
Phase 1 / 2 / 3 / 4
Drug
[ DrugBank ]
Target gene
Target pathway
Domestic patients
Med expenses recipients (FY2023)
181Crouzon syndrome [Hear] 💬
 -  20 patients
Age distribution💬
182Apert syndrome [Hear] 💬
 -  11 patients
Age distribution💬
183Pfeiffer syndrome [Hear] 💬
 -  5 patients
Age distribution💬
184Antley-Bixler syndrome [Hear] 💬
 -  3 patients
Age distribution💬
190Branchio-oto-renal syndrome [Hear] 💬
"BOR syndrome"
 -  7 patients
Age distribution💬
303Usher syndrome [Hear] 💬 [Eye] 💬
 15 trials 
  | 1 / 2 / 0 / 0 💬
 19 drugs 
 [ 5 drugs
 1 gene 
 1 pathway 
30 patients
Age distribution💬
304Juvenile-onset bilateral sensorineural hearing loss [Hear] 💬
 -  66 patients
Age distribution💬
305Delayed endolymphatic hydrops [Hear] 💬
 2 trials 
  | 0 / 0 / 0 / 0 💬
 2 drugs 
 [ 2 drugs
 31 patients
Age distribution💬
306Eosinophilic sinusitis [Imm] 💬 [Hear] 💬
 1 trial 
  | 0 / 0 / 0 / 0 💬
 2 drugs 
 [ 3 drugs
 2 genes 
 11 pathways 
28,491 patients
Age distribution💬
330Congenital tracheal stenosis [Resp] 💬 [Hear] 💬
"Congenital subglottic stenosis", "Congenital tracheal stenosis", "Congenital subglottic stenosis"
 2 trials 
  | 0 / 1 / 0 / 0 💬
 3 drugs 
 [ 2 drugs
 51 patients
Age distribution💬